Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. et al
Case Number:
1:20-cv-00133
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
- McCarter & English
- Morris James
- Phillips McLaughlin
- Pinckney Weidinger
- Potter Anderson
- Stamoulis & Weinblatt
- Young Conaway
Companies
- Apotex Inc.
- Avet Pharmaceuticals Inc.
- BionPharma Inc.
- Cadila Pharmaceuticals Ltd.
- Emcure Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd.
- Hetero Labs Ltd.
- Prinston Pharmaceutical Inc.
- Zydus Pharmaceuticals Inc.
Sectors & Industries:
-
March 02, 2020
Hetero, Zydus Settle Novartis MS Drug Suits Before IP Trial
Generic-drug makers Hetero and Zydus have each reached last-minute settlements to avoid an infringement trial set for Monday over their versions of Novartis Pharmaceuticals Corp.'s blockbuster multiple sclerosis drug Gilenya.
-
January 29, 2020
Novartis, Armed With New IP, Again Sues Over $3B MS Drug
Immediately after Novartis was granted a new patent Tuesday, the pharma giant sued a large group of generic-drug makers hoping to block their competing versions of its $3 billion multiple sclerosis drug Gilenya.